2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Dr. Rariy, Ms. Brown, and Ms. Greenman discuss how the COVID-19 pandemic has led to a significant delay in cancer diagnoses, impacted the training of oncologists, and revolutionized telehealth.
Welcome to OncLive On Air®! I’m your host today, Gina Mauro.
OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
Today, we had the pleasure of speaking with 3 female leaders from Cancer Treatment Centers of America on their predictions for oncology practice following the COVID-19 pandemic.
The panel was made up of CTCA’s chief communications officer Jaci Brown, chef information officer Jennifer Greenman, and telehealth program director Chevon M. Rariy, MD.
In our exclusive interview, the group covered how the pandemic has led to a significant delay in cancer diagnoses, has impacted the training of oncologists in training, and led to a revolution in telehealth. The predictions aligned with International Women's Day in March, and the experts shared their predictions on these various elements of cancer care in a post-pandemic world are changing.
Related Content: